With our multidisciplinary approach, we explore new ways of prognosis and treatment for clinically significant prostate cancer. We explore RNA and protein expression of prostate cancer, finding new game-changing biomarkers. By using artificial intelligence, we create algorithms for cancer recognition in pathological H&E slides and MRI images, connecting this to patient data. We seek to translate our findings into clinical everyday practice and empower the future of precision medicine.